The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
F
|
Fresenius Medical Care AG
SWB:FME
|
DE |
|
Kering SA
MIL:1KER
|
FR |
|
China Petroleum & Chemical Corp
F:CHU
|
CN |
|
P
|
Palantir Technologies Inc
F:PTX
|
US |
|
W
|
WPP PLC
DUS:0WP
|
UK |
|
K
|
Keysight Technologies Inc
F:1KT
|
US |
|
I
|
Industrivarden AB
SWB:IDVA
|
SE |
|
Mitsubishi UFJ Financial Group Inc
TSE:8306
|
JP |
|
Vodacom Group Ltd
F:5VD
|
ZA |
|
CK Asset Holdings Ltd
F:1CK
|
HK |
|
M
|
Martin Marietta Materials Inc
F:MMX
|
US |
|
C
|
China Merchants Bank Co Ltd
XMUN:M4B
|
CN |
|
C
|
CF Industries Holdings Inc
F:C4F
|
US |
|
P
|
Procter & Gamble Co
F:PRG
|
US |
|
C
|
Capital One Financial Corp
BMV:COF
|
US |
|
W
|
Western Digital Corp
XMUN:WDC
|
US |
|
E
|
EDP Renovaveis SA
DUS:EDW
|
ES |
|
F
|
First Citizens BancShares Inc (Delaware)
F:FC6A
|
US |
|
B
|
BAE Systems PLC
DUS:BSP
|
UK |
|
P
|
Patterson-UTI Energy Inc
XMUN:PE1
|
US |
|
R
|
Rockwell Automation Inc
DUS:RWL
|
US |
|
Lifetime Brands Inc
F:LH1
|
US |
|
K
|
Kirin Holdings Co Ltd
OTC:KNBWF
|
JP |
Fresenius Medical Care AG (FME)’s 12-month stock price forecast through August 2027 has a consensus target of €42.72, implying 3% upside. The forecast is based on price targets from 24 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
FME is 42.72 EUR with a low forecast of 21.88 EUR and a high forecast of 67.01 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 4%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 8 years is 5%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 8 years is 8%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 0%. The projected CAGR for the next 3 years is 9%.
Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next 8 years is 8%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more